OPTIMA MOLLITER orthotic devices have been clinically proven in randomized control trials for the treatment of foot ulceration through diabetic offloading. The OPTIMA Diab device has been shown to be clinically equivalent to total contact casts and less expensive over the course of treatment with better patient acceptance.
The next generation SBi devices that come with a removable and thermoformable liner, as well as a choice of fully rocking sole or rocker bottom sole, provide a prefabricated-customizable solution to health care providers treating diabetic foot problems.
Recently, Optima Molliter has won the “CES 2019 Innovation Awards Honoree in Wearable Technologies” for the “SBi Motus Smart” project.
“The SBi structure implemented with sensors manufactured by Sensoria (a US company specialized in the artificial intelligence sector linked to the sportswear world) gives life to the first walker in the world which monitors patients’ adherence to therapy in real time: by measuring patients’ performance and parameters 24/7, it ensures communication between medical institutions and wearers, reporting anomalies, incorrect behavior, risk situations or providing any relevant information to wearing patients.” – www.woundsource.com
The SBi Motus Smart will be available in Canada in late 2019.
V2innovations is the distributor for Saskatchewan, Eastern Ontario, Quebec, and the Maritime provinces in Canada for the Optima Molliter acute treatment products. Please contact us at email@example.com for a price list.
(Anywhere else in Canada, please contact Vittoria Phoenix for more information regarding diabetic offloading or to purchase a device.)